Research progress of PSMA PET tracers for prostate cancer
10.3760/cma.j.cn321828-20191202-00284
- VernacularTitle:前列腺癌PSMA PET显像剂研究进展
- Author:
Wenyao ZHOU
1
;
Jun ZHANG
Author Information
1. 泰州市人民医院核医学科 225300
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2020;40(12):755-760
- CountryChina
- Language:Chinese
-
Abstract:
Prostate specific membrane antigen (PSMA) targeting PET is a new imaging method for prostate cancer. Its sensitivity and specificity are better than traditional imaging methods to some extent, and PSMA ligands are also better than other commonly used PET imaging agents. The application of PSMA PET imaging mainly includes tumor localization, local staging, detection of biochemical recurrence and metastasis, and guidance for the choice of therapy. Currently, PET tracers based on PSMA are mainly 68Ga or 18F labeled compounds. This article reviews these related imaging agents.
